Soumyadeep Maity

Soumyadeep Maity

Auto-generated profile, based on publicly available information

Soumyadeep Maity

D. N. De Homoeopathic Medical College and Hospital, Kolkata, West Bengal, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2023 in Homœopathic Links
Verified
Journal Article
Closed access
PDF file
DMDibyendu Mandal
Dibyendu Mandal
SMSoumyadeep Maity
Soumyadeep Maity
ASAbdur Rahaman Shaikh
Abdur Rahaman Shaikh
SASabir Ahamed
Sabir Ahamed
PGPriyanka Ghosh
Priyanka Ghosh
SSSubhranil Saha
Subhranil Saha
Hypertension (HTN) remains one of the major risk factors for heart failure, stroke, and coronary heart disease worldwide. This study was undertaken to compare the antihypertensive effects produced by the mother tinctures (MTs) of three homeopathic drugs—Rauwolfia serpentina (RS), Viscum album (VA), and Spartium scoparium (SS; also known as Cytisus scoparius [CS]) in essential hypertension. This open-label, randomized, three parallel arm, pragmatic, pilot trial was conducted on 60 participants with essential hypertension in the outpatient department of D. N. De Homoeopathic Medical College and Hospital, Kolkata. Participants were randomized into three groups: RS, VA, and SS equally. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured at baseline and after 30 and 60 minutes. Group differences at different time points and overall were measured using one-way analysis of variance (ANOVA) and three-way repeated measure ANOVA models, respectively, after adjusting for baseline differences using intention-to-treat approaches. A p value less than 0.05 was considered statistically significant. Endpoint analysis included 60 participants. Although the highest mean reductions in SBP and DBP with time were achieved in the RS group, all three medicines revealed similar antihypertensive effects without any significant differences (SBP: F 2, 57 = 1.710, p = 0.190; DBP: F 2, 57 = 0.732, p = 0.485). No harm or serious adverse events were reported from either of the groups. All three medicines (RS, VA, and SS) produced similar antihypertensive effects in essential hypertension. Trial registration: CTRI/2021/02/031548; UTN: U1111–1264–6856. D.M., S.M., and S.K.M. were responsible for concept development and literature search. D.M., S.M., A.R.S., S.A., and P.G. contributed to clinical study and data acquisition. P.G., M.K., and S.S. were responsible for the concept, study design, data interpretation, statistical analysis, and preparation of the article. All the authors reviewed and approved the final version of the article. The data that support the findings of this study are available from the corresponding author upon reasonable request. Article published online: 16 October 2023 © 2023. Thieme. All rights reserved. Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

17 December 2025 in Advances in Integrative Medicine
Verified
Journal Article
Closed access
DMDibyendu Mandal
Dibyendu Mandal
SMSoumyadeep Maity
Soumyadeep Maity
SSSudeshna Sardar
Sudeshna Sardar
ARAbhijit Rana
Abhijit Rana
SPSrijana Panda
Srijana Panda
SSSubhranil Saha
Subhranil Saha